EUR/JPY resumes climb as yen retreats further and ECB decision looms
James Chen, CMT July 18, 2016 3:28 PM
Also weighing on the Japanese yen since last week have been concrete promises of a new round of comprehensive monetary easing measures from Japan’s Prime Minister Shinzo Abe and his reinvigorated Abenomics stimulus policies.
Meanwhile, from the European side, the euro was modestly higher overall on Monday, but has generally been range-bound against the US dollar since its sharp fall in the immediate aftermath of June’s Brexit vote. Coming up on Thursday this week will be another major risk event for the euro – the European Central Bank’s (ECB) rate decision and press conference. In the event that the habitually dovish ECB indicates even more aggressive stimulus measures, it could mean a further fall for the euro against its major currency counterparts.
These two complementary, yet conflicting, forces – Japanese stimulus and European stimulus – are likely to impart heightened volatility on EUR/JPY for the next few weeks, potentially pulling the currency pair in opposing directions.
As it currently stands, the risk-on market environment coupled with the virtually inevitable monetary easing by Japan has boosted EUR/JPY from near its multi-year lows around 111.00 support last week up to approach the 118.00 resistance level. This level is also where the 50-day moving average is currently situated, as well as the 50% Fibonacci retracement of the down-move from the late-April high down to the post-Brexit low. With any continued upside move above this resistance as Japan’s monetary policy unfolds, the next major short-term target is around the key 122.00 resistance level. The ECB decision on Thursday, however, could very well hinder EUR/JPY’s rebound, potentially prompting the currency pair to turn back down below 116.00 to target the noted 111.00 support level once again.
Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.
Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to Forex.com or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.